Unlocking Protein Therapeutics Potential: Aura PTx for Advanced Stability Studies

News
Webcast

Webcasts

Webinar Date/Time: Wed, Mar 19, 2025 1:00 PM EDT

Join Dikran Khachadourian as he introduces the Aura PTx platform, a groundbreaking tool from Halo Labs that uses advanced imaging and fluorescence microscopy to streamline protein stability studies. Discover how this low-volume, high-throughput system accelerates biologics development by rapidly sizing, counting, and characterizing proteins, particles, and more in mixed samples.

Register Free: https://www.biopharminternational.com/bp_w/advanced-stability-studies

Event Overview:

The success of protein therapeutics depends on their efficacy, safety, and stability. Specifically, stability studies play a crucial role in identifying factors that lead to aggregation and degradation. Traditional methods for analyzing stability often require large sample volumes, are time-consuming, and lack reliability. In this webinar, Dikran Khachadourian will introduce Halo Labs’ innovative Aura® PTx platform, which uses advanced imaging and fluorescence microscopy to rapidly size, count, and characterize proteins and other particles in mixed samples with minimal volumes. Attendees will explore its key applications, including developability assessments and USP788 testing.

Key Learning Objectives:

  • Master protein, particle, and product characterization as early as early-phase development using only 5uL of sample leveraging a modernized approach of membrane microscopy.
  • Explore how Fluorescence Membrane Microscopy (FMM) can be used to differentiate between subpopulations of particulates, such as protein aggregates, polysorbate degradants, and extrinsic contaminants.
  • Learn why Backgrounded Membrane Imaging (BMI) has become an emerging technique for lot release testing and generating USP 788-compliant data.


Who Should Attend:

  • Protein therapy developers
  • Formulations development scientists
  • Development scientists
  • Biophysical characterization scientists
  • Developability scientists
  • Protein characterization scientists
  • QA/QC faculty

Speaker:

Dikran Khachadourian
Field Application Scientist
Halo Labs

Dikran Khachadourian is a field application scientist at Halo Labs. Khachadourian completed his undergraduate studies at UC San Diego, obtaining a bachelor's degree in biochemistry and cell biology. His interest in the biological sciences led him to pursue a master’s degree in biology. After spending time in academia as a graduate researcher and educator, Khachadourian joined the Halo Labs team to apply his background to the ongoing advancements in biotechnology.


Register Free: https://www.biopharminternational.com/bp_w/advanced-stability-studies

Recent Videos
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
David Fairen-Jimenez
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa Solutions
Eswar Iyer, Aikium Inc.
Leroy (Lee) Hood, MD, PhD
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
© 2025 MJH Life Sciences

All rights reserved.